The Expanding Role of GLP-1 Agonists in Psychiatry

Evidence and Therapeutic Potential in Key Comorbidities

CNS Penetrance &
NeuroGenesis, NeuroDifferentiation,
NeuroPlasticity = Neuro-GDP
Obesity & Weight Mgt.
Metabolic Syndrome X
Disordered Eating
Depression & Anxiety
Alcohol Use Disorder
Tobacco & Cannabis Use
Impulse Control Disorders
Neurocognition & AD
Click on the green dots to explore the evidence for each psychiatric application.